STZ Constellation Brands Inc

$-0.08 (-0.04%)

STZ Stock Analysis Overview

What this means: Constellation Brands Inc (STZ) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. STZ's 63 means that it ranks higher than 63% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full STZ report

Constellation Brands Inc (STZ) Analyst Forecast

Next 12 months ➝Current Price$185.8052-week High$212.0052-week Low$104.28MEAN$187.17+0.74%HIGH$230.00+23.79%LOW$147.00-20.88%
  • Last Price$185.80
  • Previous Close$185.88
  • Change $-0.08
  • Open$189.18
  • Volume1,895,062
  • Avg. Volume (100-day)1,767,246
  • Market Capitalization$36B
  • Days Range $185.39 - $190.74
  • 52-week Range $104.28 - $212.00
  • Dividend Yield1.62%
  • Ex. Dividend Date08/10/2020
  • P-E774.2
  • EPS0.24
  • Earnings Date09/29/2020
  • SectorConsumer Defensive
  • IndustryBeverages - Wineries & Distilleries
  • Avg. Analyst Rec.
  • Beta1.243
  • PEG Ratio3.08
  • Volatility0.39
  • Average True Range0.03
Constellation Brands Inc is the multi-category alcohol supplier in the U.S. The business is anchored by a portfolio of Mexican beer trademarks, including Corona and Modelo, for which it acquired exclusive and perpetual U.S. ownership from AB InBev. The latter had to divest these rights due to antitrust mandates as it consummated its 2013 acquisition of dominant Mexican brewer, Grupo Modelo. Constellation's wine/spirits business has been in flux, and it is currently divesting several lower-margin assets, including myriad wine brands and its Ballast Point craft beer brand. The firm imports most products after manufacturing them abroad, going to market through independent wholesalers. It owns 37% of Canopy Growth, a leading provider of medicinal and recreationally legal cannabis products.